Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease

被引:51
作者
Pejhan, Shervin [2 ]
Rastegar, Mojgan [1 ]
机构
[1] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Regenerat Med Program, Winnipeg, MB R3E 0J9, Canada
[2] Western Univ, Schulich Sch Med & Dent, Dept Pathol & Lab Med, Neuropathol Program, London, ON N6A 5C, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
epigenetics; DNA methylation; MeCP2; isoforms; BDNF; miR132; brain development; Rett syndrome; RTT pathobiology;
D O I
10.3390/biom11010075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rett Syndrome (RTT) is a severe, rare, and progressive developmental disorder with patients displaying neurological regression and autism spectrum features. The affected individuals are primarily young females, and more than 95% of patients carry de novo mutation(s) in the Methyl-CpG-Binding Protein 2 (MECP2) gene. While the majority of RTT patients have MECP2 mutations (classical RTT), a small fraction of the patients (atypical RTT) may carry genetic mutations in other genes such as the cyclin-dependent kinase-like 5 (CDKL5) and FOXG1. Due to the neurological basis of RTT symptoms, MeCP2 function was originally studied in nerve cells (neurons). However, later research highlighted its importance in other cell types of the brain including glia. In this regard, scientists benefitted from modeling the disease using many different cellular systems and transgenic mice with loss- or gain-of-function mutations. Additionally, limited research in human postmortem brain tissues provided invaluable findings in RTT pathobiology and disease mechanism. MeCP2 expression in the brain is tightly regulated, and its altered expression leads to abnormal brain function, implicating MeCP2 in some cases of autism spectrum disorders. In certain disease conditions, MeCP2 homeostasis control is impaired, the regulation of which in rodents involves a regulatory microRNA (miR132) and brain-derived neurotrophic factor (BDNF). Here, we will provide an overview of recent advances in understanding the underlying mechanism of disease in RTT and the associated genetic mutations in the MECP2 gene along with the pathobiology of the disease, the role of the two most studied protein variants (MeCP2E1 and MeCP2E2 isoforms), and the regulatory mechanisms that control MeCP2 homeostasis network in the brain, including BDNF and miR132.
引用
收藏
页码:1 / 27
页数:27
相关论文
共 251 条
  • [1] MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production
    Abuhatzira, Liron
    Makedonski, Kirill
    Kaufman, Yotam
    Razin, Aharon
    Shemer, Ruth
    [J]. EPIGENETICS, 2007, 2 (04) : 214 - 222
  • [2] Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2
    Adams, Valerie H.
    McBryant, Steven J.
    Wade, Paul A.
    Woodcock, Christopher L.
    Hansen, Jeffrey C.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (20) : 15057 - 15064
  • [3] Mouse and rat BDNF gene structure and expression revisited
    Aid, Tamara
    Kazantseva, Anna
    Piirsoo, Marko
    Palm, Kaia
    Timmusk, Tonis
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2007, 85 (03) : 525 - 535
  • [4] Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
    Amir, RE
    Van den Veyver, IB
    Wan, M
    Tran, CQ
    Francke, U
    Zoghbi, HY
    [J]. NATURE GENETICS, 1999, 23 (02) : 185 - 188
  • [5] Chronic Ethanol Exposure Alters DNA Methylation in Neural Stem Cells: Role of Mouse Strain and Sex
    Amiri, Shayan
    Davie, James R.
    Rastegar, Mojgan
    [J]. MOLECULAR NEUROBIOLOGY, 2020, 57 (02) : 650 - 667
  • [6] Distinct role of long 3′ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons
    An, Juan Ji
    Gharami, Kusumika
    Liao, Guey-Ying
    Woo, Newton H.
    Lau, Anthony G.
    Vanevski, Filip
    Torre, Enrique R.
    Jones, Kevin R.
    Feng, Yue
    Lu, Bai
    Xu, Baoji
    [J]. CELL, 2008, 134 (01) : 175 - 187
  • [7] Correlation between clinical severity in patients with Rett Syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation
    Archer, Hayley
    Evans, Julie
    Leonard, Helen
    Colvin, Lyn
    Ravine, David
    Christodoulou, John
    Williamson, Sarah
    Charman, Tony
    Bailey, Mark E. S.
    Sampson, Julian
    de Klerk, Nicholas
    Clarke, Angus
    [J]. JOURNAL OF MEDICAL GENETICS, 2007, 44 (02) : 148 - 152
  • [8] SELECTIVE DENDRITIC ALTERATIONS IN THE CORTEX OF RETT-SYNDROME
    ARMSTRONG, D
    DUNN, JK
    ANTALFFY, B
    TRIVEDI, R
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (02) : 195 - 201
  • [9] Neuropathology of Rett syndrome
    Armstrong, DD
    [J]. JOURNAL OF CHILD NEUROLOGY, 2005, 20 (09) : 747 - 753
  • [10] Neuropathology of Rett syndrome
    Armstrong, DD
    [J]. MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2002, 8 (02): : 72 - 76